These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2049690)

  • 21. Mechanisms of arrhythmias: enhanced automaticity and reentry.
    Weller DM; Noone J
    Crit Care Nurse; 1989 May; 9(5):42-67. PubMed ID: 2680278
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A class III antiarrhythmic agent.
    Pelter MM; Adams MG
    Am J Crit Care; 2002 Jul; 11(4):395-6. PubMed ID: 12102441
    [No Abstract]   [Full Text] [Related]  

  • 23. Electrophysiological basis for a rational approach to antidysrhythmic drug therapy.
    Williams EM
    Adv Drug Res; 1974; 9():69-101. PubMed ID: 4618979
    [No Abstract]   [Full Text] [Related]  

  • 24. Problems of antiarrhythmic treatment in children.
    Coumel P; Fidelle J
    Cardiologia; 1983 Sep; 28(9):767-82. PubMed ID: 6687332
    [No Abstract]   [Full Text] [Related]  

  • 25. [Side effects of anti-arrhythmia drugs].
    Neugebauer A
    Z Gesamte Inn Med; 1984 Jun; 39(11):249-52. PubMed ID: 6475169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Utilization of ambulatory electrocardiographic monitoring and exercise stress testing to assess antiarrhythmic drug efficacy.
    Graboys TB
    Cardiologia; 1983 Sep; 28(9):803-10. PubMed ID: 6687334
    [No Abstract]   [Full Text] [Related]  

  • 27. [Control of the efficacy of anti-arrhythmic treatments].
    Coumel P
    Schweiz Med Wochenschr; 1981 Nov; 111(45):1688-91. PubMed ID: 7313633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antiarrhythmic drug therapy and prevention of cardiac emergencies in the prehospital phase].
    von Knorre GH
    Z Arztl Fortbild (Jena); 1984; 78(15):621-2. PubMed ID: 6495771
    [No Abstract]   [Full Text] [Related]  

  • 29. Antiarrhythmic drug therapy: new drugs and changing concepts.
    Reiser HJ; Sullivan ME
    Fed Proc; 1986 Jul; 45(8):2206-12. PubMed ID: 2873062
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ambulatory cardiac monitoring for the evaluation of antiarrhythmic agents.
    Antczak-Bouckoms A; Tulloch JF; Adams ME
    Int J Technol Assess Health Care; 1993; 9(1):124-38. PubMed ID: 8423111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Electrically induced arrhythmias in the rat.
    Walker MJ; Beatch GN
    Proc West Pharmacol Soc; 1988; 31():167-70. PubMed ID: 3211899
    [No Abstract]   [Full Text] [Related]  

  • 32. Malignant arrhythmias: tribulations post ESVEM.
    Murgatroyd F
    Lancet; 1993 Sep; 342(8871):569. PubMed ID: 8102715
    [No Abstract]   [Full Text] [Related]  

  • 33. Management of ventricular arrhythmias.
    Aronow WS
    Compr Ther; 1988 Aug; 14(8):25-30. PubMed ID: 3048863
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rational use of antiarrhythmic drugs alone and in combination.
    Bigger JT; Giardina EG
    Cardiovasc Clin; 1974; 6(2):103-17. PubMed ID: 4613454
    [No Abstract]   [Full Text] [Related]  

  • 35. [Validity of the study of the electrophysiological effects of anti-arrhythmia drugs in man prior to modern antiarrhythmic therapy. Multicenter study].
    Disertori M; Furlanello F; Botti G; Bonatti V; Critelli G; Adinolfi L; Lotto A; Finzi A; Masoni A; Alboni P; Rizzon P; Di Biase M; Salerno JA; Chimienti M; Costantini M; Santini M; Dini P
    Boll Soc Ital Cardiol; 1980; Suppl():101-15. PubMed ID: 6760884
    [No Abstract]   [Full Text] [Related]  

  • 36. CL-845 (pirmenol hydrochloride): a new orally effective long-acting antiarrhythmic agent.
    Steffe TJ; Mertz TE; Hastings SG; Potoczak RE; Kaplan HR
    J Pharmacol Exp Ther; 1980 Jul; 214(1):50-7. PubMed ID: 7391970
    [No Abstract]   [Full Text] [Related]  

  • 37. [Drug therapy of arrhythmia--ECG, a "cosmetic" or benefit to the patient?].
    Toivonen L; Heikkilä J
    Duodecim; 1986; 102(22):1651-61. PubMed ID: 3803255
    [No Abstract]   [Full Text] [Related]  

  • 38. [The effect of naloxone on rhythm disorders and on the conduction system of the heart].
    Shliakhto EV; Zaĭtsev AA; Panov AV; Ardashev AV; Nifontov EM; Kashina EA; Kazarin VV; Ivanov VV
    Eksp Klin Farmakol; 1996; 59(3):34-6. PubMed ID: 8974581
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Plasma levels of anti-arrhythmic drugs and clinical effectiveness in the treatment of ventricular arrhythmias].
    Bracchetti D; Naccarella F; Guaragna RF; Palmieri M; Bartoletti A; Barbato G; Malini PL; Marchesini B; Ambrosioni E
    G Ital Cardiol; 1986 Aug; 16(8):648-59. PubMed ID: 3539687
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New drugs for the treatment of cardiac arrhythmias.
    Bump TE; Arnsdorf MF
    Compr Ther; 1980 Jun; 6(6):63-72. PubMed ID: 6103779
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.